Name | APTEKA N109, OAO |
|---|
INN | 7328042283 |
|---|
KPP | 732801001 |
|---|
OGRN | 1027301572363 |
|---|
OKPO | 25266354 |
|---|
FFSM | 02004-E |
|---|
Address | 432046, Ul'yanovskaya Oblast', g. Ul'yanovsk, ul. 40-letiya Oktyabrya, d. D.9 |
|---|
Phone | +7 (842) 255-07-64 Contact details |
|---|
Fax | +7 (842) 252-17-49 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 14.10.2002 |
|---|
Registering department | Administratsiya Zavolzhskogo rayona g.Ul'yanovska |
|---|
|
APTEKA N109, OAO (Ulyanovsk Oblast; INN 7328042283) was registered on 14 Oct 2002. The company's authorized capital as of July 1, 2012 was 622000 rub. Type of ownership of APTEKA N109, OAO - Open joint-stock companies. Form of ownership of APTEKA N109, OAO - Combined Russian property with a share of the property of constituent entities of the Russian Federation. Principal activities of APTEKA N109, OAO: retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of APTEKA N109, OAO dropped in 2023 by 10.29% to 122.00 thousand RUB from 136.00 thousand RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 8.36% to 28.56 million RUB from 31.17 million RUB in 2022; cost of goods sold decreased by 8.38% to 23.04 million RUB from 25.15 million RUB; sales profit went up 5.88 times to 147.00 thousand RUB from 25.00 thousand RUB. 2022
Net profit (RAS) of APTEKA N109, OAO grew over 2022 by 30.77% to 136.00 thousand RUB from 104.00 thousand RUB over 2021, the company informed. Revenue remained in the accounting period at the same level and made up 31.17 million RUB compared to 31.12 million RUB 31.12 million RUB; cost of goods sold remained at the same level amounting to 25.15 million RUB compared to 25.16 million RUB; sales profit fell 9.16 times to 25.00 thousand RUB from 229.00 thousand RUB. 2021
Net profit (RAS) of APTEKA N109, OAO dropped in 2021 by 9.57% to 104.00 thousand RUB from 115.00 thousand RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 0.50% to 31.12 million RUB from 31.28 million RUB in 2020; cost of goods sold remained at the same level amounting to 25.16 million RUB compared to 25.25 million RUB; sales profit fell by 15.81% to 229.00 thousand RUB from 272.00 thousand RUB. 2020
Net profit (RAS) of APTEKA N109, OAO grew over 2020 2.67 times to 115.00 thousand RUB from 43.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 20.00% to 31.28 million RUB from 26.06 million RUB over 2019; cost of goods sold grew by 21.38% to 25.25 million RUB from 20.80 million RUB; sales profit went up 1.54 times to 272.00 thousand RUB from 177.00 thousand RUB. 2019
Net profit (RAS) of APTEKA N109, OAO grew over 2019 by 30.30% to 43.00 thousand RUB from 33.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 13.52% to 26.06 million RUB from 22.96 million RUB over 2018; cost of goods sold grew by 13.11% to 20.80 million RUB from 18.39 million RUB; sales profit went up 1.51 times to 177.00 thousand RUB from 117.00 thousand RUB. 2018
Net profit (RAS) of APTEKA N109, OAO grew over 2018 by 13.79% to 33.00 thousand RUB from 29.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 11.39% to 22.96 million RUB from 20.61 million RUB over 2017; cost of goods sold grew by 11.05% to 18.39 million RUB from 16.56 million RUB; sales profit went up by 13.59% to 117.00 thousand RUB from 103.00 thousand RUB. 2017
Net profit (RAS) of APTEKA N109, OAO grew over 2017 1.93 times to 29.00 thousand RUB from 15.00 thousand RUB over 2016, the company informed. Revenue decreased in the accounting period by 2.91% to 20.61 million RUB from 21.23 million RUB in 2016; cost of goods sold decreased by 3.59% to 16.56 million RUB from 17.18 million RUB; sales profit made up 103.00 thousand RUB compared to sales loss of 23.00 thousand RUB. 2016
Net profit (RAS) of APTEKA N109, OAO grew over 2016 1.88 times to 15.00 thousand RUB from 8.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period by 8.89% to 21.23 million RUB from 19.50 million RUB over 2015; cost of goods sold grew by 8.56% to 17.18 million RUB from 15.82 million RUB; sales loss made up 23.00 thousand RUB compared to sales profit of 77.00 thousand RUB. 2014
Net profit (RAS) of Apteka N109, OAO grew over 2014 1.50 times to 3.00 thousand RUB from 2.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 9.24% to 15.60 million RUB from 14.28 million RUB over 2013; cost of goods sold grew by 8.25% to 12.52 million RUB from 11.57 million RUB; sales profit went up by 26.09% to 87.00 thousand RUB from 69.00 thousand RUB. 2013
Net profit (RAS) of Apteka N109, OAO made up 2.00 thousand RUB over 2013 compared to net loss of 85.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 7.91% to 14.28 million RUB from 13.24 million RUB over 2012; cost of goods sold grew by 7.59% to 11.57 million RUB from 10.75 million RUB; sales profit made up 69.00 thousand RUB compared to sales loss of 92.00 thousand RUB. 2012
Net loss (RAS) of Apteka N109, OAO dropped over 2012 5.14 times to 85.00 thousand RUB from 437.00 thousand RUB KAgent.Entities.Balance, the company informed. Cost of goods sold decreased by 12.67% to 10.75 million RUB from 12.31 million RUB; sales loss decreased 5.61 times to 92.00 thousand RUB from 516.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|